Statistics for COVID-19 pandemic and allergen immunotherapy—an EAACI survey
Total visits
| views | |
|---|---|
| COVID-19 pandemic and allergen immunotherapy—an EAACI survey | 92 |
Total visits per month
| views | |
|---|---|
| June 2024 | 15 |
| July 2024 | 4 |
| August 2024 | 4 |
| September 2024 | 8 |
| October 2024 | 2 |
| November 2024 | 3 |
| December 2024 | 0 |
File Visits
| views | |
|---|---|
| Covid_Pfaar_et_al_Allergy_2021.pdf | 15 |
Top country views
| views | |
|---|---|
| Spain | 34 |
| United States | 29 |
| Australia | 8 |
| China | 6 |
| Russia | 6 |
| Singapore | 3 |
| Mongolia | 2 |
| Argentina | 1 |
| United Kingdom | 1 |
| India | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Madrid | 25 |
| San Mateo | 4 |
| Seville | 4 |
| Krasnogorsk | 3 |
| Alicante | 2 |
| Auburn | 2 |
| Melbourne | 2 |
| Moscow | 2 |
| Qingdao | 2 |
| Valencia | 2 |
| Brisbane | 1 |
| Canberra | 1 |
| Dezhou | 1 |
| Mumbai | 1 |
| Noginsk | 1 |
| Odesa | 1 |
| Perth | 1 |
| Tordera | 1 |
| Xiamen | 1 |